1 insider has bought $89k of Shuttle Pharmaceuticals Holdings, Inc. shares across 1 disclosed dealing since June 2026.
| Jun 29, 2026 | HRT FINANCIAL LP — 10% owner | $88,876 |
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.